Novel Opioid Receptor Drug Cuts IPF Cough

By News Health
1 hour Ago

(MedPage Today) — The novel opioid agonist/antagonist nalbuphine offered relief from chronic cough associated with idiopathic pulmonary fibrosis (IPF), the phase IIb CORAL trial showed.
Nalbuphine extended release (ER) reduced objective cough…

Source link : https://www.medpagetoday.com/pulmonology/generalpulmonary/119552

Author :

Publish date : 2026-01-23 15:24:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

The New Eugenics in Medicine

The Doctor Entrepreneur: MENA’s New Healthcare Innovators

Trump Administration Halts Use of Human Fetal Tissue in NIH-Funded Research

U.S. Completes Its WHO Withdrawal

Bill O'Reilly's Illness; Striking Nurses Asking for $200,000; FDA Warns Test Makers

Export Ban Fails to Stem UK Aspirin Shortages